UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Three-Dimensional Dynamic Random Access Memories Using Through-Silicon-Vias

IEEE journal on emerging and selected topics in circuits and systems, 2016-09, Vol.6 (3), p.373-384

2016

Volltextzugriff (PDF)

A 3D system prototype of an eDRAM cache stacked over processor-like logic using through-silicon vias

2012 IEEE International Solid-State Circuits Conference, 2012, p.186-187

2012

Volltextzugriff (PDF)

Absorption, Metabolism, and Excretion of 14C-Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) in Healthy Male Subjects

Antimicrobial agents and chemotherapy, 2023-04, Vol.67 (4), p.e0150922

2023

Volltextzugriff (PDF)

Personal Accounts: Bringing Grandma Home

Psychiatric services (Washington, D.C.), 2005-04, Vol.56 (4), p.416-417

Maier, Gary J

2005

Volltextzugriff (PDF)

Absorption, Metabolism, and Excretion of [ 14 C]-Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) in Healthy Male Subjects

Antimicrobial agents and chemotherapy, 2023-04, Vol.67 (4), p.e0150922

2023

Volltextzugriff (PDF)

Three-Dimensional Wafer Stacking Using Cu TSV Integrated with 45 nm High Performance SOI-CMOS Embedded DRAM Technology

Journal of low power electronics and applications, 2014-05, Vol.4 (2), p.77-89

2014

Volltextzugriff (PDF)

Bringing grandma home

Psychiatric services (Washington, D.C.), 2005-04, Vol.56 (4), p.416-417

Maier, Gary J

2005

Volltextzugriff (PDF)

Randomized, Double-Blind, Placebo- and Positive-Controlled Crossover Study of the Effects of Tebipenem Pivoxil Hydrobromide on QT/QTc Intervals in Healthy Subjects

Antimicrobial agents and chemotherapy, 2021-06, Vol.65 (7), p.e0014521

2021

Volltextzugriff (PDF)

A phase 2a safety run-in and preliminary efficacy study of liposomal gemcitabine (FF-10832) in combination with pembrolizumab in patients with advanced solid tumors

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.2615-2615

2024

Volltextzugriff (PDF)

Known-good-die test methods for large, thin, high-power digital devices

2016 IEEE International Test Conference (ITC), 2016, p.1-6

2016

Volltextzugriff (PDF)

A first-in-human phase 1 dose escalation study of FF-10850 (liposomal topotecan) in patients with advanced solid tumors

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.3101-3101

2022

Volltextzugriff (PDF)

A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside analog FF‐10502‐01 for the treatment of advanced solid tumors

Cancer, 2023-05, Vol.129 (10), p.1537-1546

2023

Volltextzugriff (PDF)

A phase 1, first-in-human, dose-escalation and biomarker trial of liposomal gemcitabine (FF-10832) in patients with advanced solid tumors

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.3097-3097

2022

Volltextzugriff (PDF)

Phase 1 first-in-human study of irreversible FLT3 inhibitor FF-10101-01 in relapsed or refractory acute myeloid leukemia

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.7008-7008

2021

Volltextzugriff (PDF)

1120. Absorption, Metabolism, and Excretion of [14C]-Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Following a Single Oral Dose in Healthy Male Subjects

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S652-S652

2021

Volltextzugriff (PDF)

2556. A Phase 1, Open-Label, Single Dose Study to Evaluate the Pharmacokinetics (PK), Safety, and Tolerability of Epetraborole Tablets and the Impact of Alcohol Dehydrogenase (ADH) Genotype on the PK of Epetraborole and Metabolite M3 in Healthy Japanese Adult Subjects

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

2023

Volltextzugriff (PDF)

A phase I dose-escalation and immune biomarker study of intravenous FF-10832, liposomal gemcitabine, in patients with advanced solid tumors

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.TPS3163-TPS3163

2019

Volltextzugriff (PDF)

Results of a Phase 1, Dose-Escalation Study of FF-10501-01 in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) or Hypomethylating Agent (HMA)-Resistant Myelodysplastic Syndrome (MDS)

Blood, 2018-11, Vol.132 (Supplement 1), p.1438-1438

2018

Volltextzugriff (PDF)

Imaging Drugs with and without Clinical Analgesic Efficacy

Neuropsychopharmacology (New York, N.Y.), 2011-12, Vol.36 (13), p.2659-2673

2011

Volltextzugriff (PDF)

2144. A Phase 1, Multicenter, Open-Label, Parallel-Group Study to Assess the Safety and Pharmacokinetics (PK) of Oral Epetraborole Tablets in Adult Subjects with Varying Degrees of Renal Function

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

2023

Volltextzugriff (PDF)

A phase 1 study of the irreversible FLT3 inhibitor FF-10101 in relapsed or refractory acute myeloid leukemia

Blood advances, 2024-05, Vol.8 (10), p.2527-2535

2024

Volltextzugriff (PDF)

Phase 1/2 trial of FF-10502-01, a pyrimidine antimetabolite, in patients with advanced cholangiocarcinoma and solid tumors

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.3008-3008

2019

Volltextzugriff (PDF)

Results of a Phase 1/2a dose-escalation study of FF-10501-01, an IMPDH inhibitor, in patients with acute myeloid leukemia or myelodysplastic syndromes

Leukemia & lymphoma, 2020-07, Vol.61 (8), p.1943-1953

2020

Volltextzugriff (PDF)

Modulation of CNS pain circuitry by intravenous and sublingual doses of buprenorphine

NeuroImage (Orlando, Fla.), 2012-02, Vol.59 (4), p.3762-3773

2012

Volltextzugriff (PDF)

1 – 25 von 228

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(199)
Mit Volltextzugriff
(188)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(128)
Life Sciences & Biomedicine
(102)
Humans
(83)
Male
(51)
Female
(38)
Biological And Medical Sciences
(31)
Medical Sciences
(27)
Adult
(26)
Animals
(23)
Psychiatry
(22)
Neurosciences & Neurology
(18)
Middle Aged
(15)
Technology
(15)
Public, Environmental & Occupational Health
(14)
Engineering
(12)
Science & Technology - Other Topics
(12)
Aged
(11)
Neurosciences
(11)
Pharmacology & Pharmacy
(11)
Pharmacology. Drug Treatments
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Three-Dimensional Dynamic Random Access Memories Using Through-Silicon-Vias

A 3D system prototype of an eDRAM cache stacked over processor-like logic using through-silicon vias

Absorption, Metabolism, and Excretion of 14C-Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) in Healthy Male Subjects

Personal Accounts: Bringing Grandma Home

Absorption, Metabolism, and Excretion of [ 14 C]-Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) in Healthy Male Subjects

Three-Dimensional Wafer Stacking Using Cu TSV Integrated with 45 nm High Performance SOI-CMOS Embedded DRAM Technology

Bringing grandma home

Randomized, Double-Blind, Placebo- and Positive-Controlled Crossover Study of the Effects of Tebipenem Pivoxil Hydrobromide on QT/QTc Intervals in Healthy Subjects

A phase 2a safety run-in and preliminary efficacy study of liposomal gemcitabine (FF-10832) in combination with pembrolizumab in patients with advanced solid tumors

Efficient AI System Design With Cross-Layer Approximate Computing

Known-good-die test methods for large, thin, high-power digital devices

A first-in-human phase 1 dose escalation study of FF-10850 (liposomal topotecan) in patients with advanced solid tumors

A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside analog FF‐10502‐01 for the treatment of advanced solid tumors

A phase 1, first-in-human, dose-escalation and biomarker trial of liposomal gemcitabine (FF-10832) in patients with advanced solid tumors

Phase 1 first-in-human study of irreversible FLT3 inhibitor FF-10101-01 in relapsed or refractory acute myeloid leukemia

1120. Absorption, Metabolism, and Excretion of [14C]-Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Following a Single Oral Dose in Healthy Male Subjects

2556. A Phase 1, Open-Label, Single Dose Study to Evaluate the Pharmacokinetics (PK), Safety, and Tolerability of Epetraborole Tablets and the Impact of Alcohol Dehydrogenase (ADH) Genotype on the PK of Epetraborole and Metabolite M3 in Healthy Japanese Adult Subjects

A phase I dose-escalation and immune biomarker study of intravenous FF-10832, liposomal gemcitabine, in patients with advanced solid tumors

Results of a Phase 1, Dose-Escalation Study of FF-10501-01 in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) or Hypomethylating Agent (HMA)-Resistant Myelodysplastic Syndrome (MDS)

Imaging Drugs with and without Clinical Analgesic Efficacy

2144. A Phase 1, Multicenter, Open-Label, Parallel-Group Study to Assess the Safety and Pharmacokinetics (PK) of Oral Epetraborole Tablets in Adult Subjects with Varying Degrees of Renal Function

A phase 1 study of the irreversible FLT3 inhibitor FF-10101 in relapsed or refractory acute myeloid leukemia

Phase 1/2 trial of FF-10502-01, a pyrimidine antimetabolite, in patients with advanced cholangiocarcinoma and solid tumors

Results of a Phase 1/2a dose-escalation study of FF-10501-01, an IMPDH inhibitor, in patients with acute myeloid leukemia or myelodysplastic syndromes

Modulation of CNS pain circuitry by intravenous and sublingual doses of buprenorphine

Suchergebnisse filtern